A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS [version 1; peer review: 1 approved, 3 approved with reservations]

Background: Acute respiratory distress syndrome (ARDS) is a severe critical condition with a high mortality that is currently in focus given that it is associated with mortality caused by coronavirus disease 2019 (COVID-19). Neutrophils play a key role in the lung injury characteristic of non-COVID-...

Full description

Bibliographic Details
Main Authors:	Leila Reyes, Manuel A. Sanchez-Garcia, Tyler Morrison, Andy J. M. Howden, Emily R. Watts, Simone Arienti, Pranvera Sadiku, Patricia Coelho, Ananda S. Mirchandani, Ailiang Zhang, David Hope, Sarah K. Clark, Jo Singleton, Shonna Johnston, Robert Grecian, Azin Poon, Sarah McNamara, Isla Harper, Max Head Fourman, Alejandro J. Brenes, Shalini Pathak, Amy Lloyd, Giovanny Rodriguez Blanco, Alex von Kriegsheim, Bart Ghesquiere, Wesley Vermaelen, Camila T. Cologna, Kevin Dhaliwal, Nik Hirani, David H. Dockrell, Moira K. B. Whyte, David Griffith, Doreen A. Cantrell, Sarah R. Walmsley
Format:	Article
Language:	English
Published:	Wellcome 2021-02-01
Series:	Wellcome Open Research
Online Access:	https://wellcomeopenresearch.org/articles/6-38/v1

Internet

https://wellcomeopenresearch.org/articles/6-38/v1

­­­­­­­A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS­­­ [version 1; peer review: 1 approved, 3 approved with reservations]

Internet

Similar Items

A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS [version 1; peer review: 1 approved, 3 approved with reservations]